TrialThe journals of gerontology. Series A, Biological sciences and medical sciences2019

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial.

Kenneth E Schmader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.